nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Phenylpropanolamine—obesity	0.43	1	CrCtD
Levonordefrin—Metaraminol—Phenylpropanolamine—obesity	0.0983	0.47	CrCrCtD
Levonordefrin—Phenylpropanolamine—Phentermine—obesity	0.0587	0.28	CrCrCtD
Levonordefrin—Phenylpropanolamine—Methamphetamine—obesity	0.0523	0.25	CrCrCtD
Levonordefrin—SLC6A2—Diethylpropion—obesity	0.0331	0.106	CbGbCtD
Levonordefrin—SLC6A2—Sibutramine—obesity	0.0251	0.0803	CbGbCtD
Levonordefrin—SLC6A2—Phendimetrazine—obesity	0.0251	0.0803	CbGbCtD
Levonordefrin—ADRA1A—Phendimetrazine—obesity	0.0217	0.0694	CbGbCtD
Levonordefrin—ADRA2C—Methamphetamine—obesity	0.0208	0.0665	CbGbCtD
Levonordefrin—ADRA2B—Methamphetamine—obesity	0.0197	0.0631	CbGbCtD
Levonordefrin—SLC6A2—Phentermine—obesity	0.019	0.0609	CbGbCtD
Levonordefrin—SLC6A2—Benzphetamine—obesity	0.019	0.0609	CbGbCtD
Levonordefrin—SLC6A2—Phenylpropanolamine—obesity	0.0181	0.0581	CbGbCtD
Levonordefrin—ADRA2A—Benzphetamine—obesity	0.0171	0.0549	CbGbCtD
Levonordefrin—ADRA1A—Benzphetamine—obesity	0.0164	0.0526	CbGbCtD
Levonordefrin—ADRA2A—Phenylpropanolamine—obesity	0.0163	0.0524	CbGbCtD
Levonordefrin—SLC6A2—Bupropion—obesity	0.0162	0.0518	CbGbCtD
Levonordefrin—ADRA1A—Phenylpropanolamine—obesity	0.0157	0.0502	CbGbCtD
Levonordefrin—SLC6A2—Methamphetamine—obesity	0.0152	0.0487	CbGbCtD
Levonordefrin—ADRA2A—Methamphetamine—obesity	0.0137	0.0439	CbGbCtD
Levonordefrin—SLC6A2—sympathetic nervous system—obesity	0.00152	0.268	CbGeAlD
Levonordefrin—SLC6A2—autonomic nervous system—obesity	0.00102	0.18	CbGeAlD
Levonordefrin—ADRA1A—hindbrain—obesity	0.000399	0.0706	CbGeAlD
Levonordefrin—Isoprenaline—PIK3R1—obesity	0.000282	0.124	CrCbGaD
Levonordefrin—SLC6A2—respiratory system—obesity	0.000262	0.0464	CbGeAlD
Levonordefrin—ADRA2A—islet of Langerhans—obesity	0.000196	0.0347	CbGeAlD
Levonordefrin—ADRA2C—adrenal cortex—obesity	0.000195	0.0345	CbGeAlD
Levonordefrin—ADRA1A—cardiovascular system—obesity	0.000187	0.033	CbGeAlD
Levonordefrin—ADRA1A—adipose tissue—obesity	0.000165	0.0291	CbGeAlD
Levonordefrin—SLC6A2—adrenal gland—obesity	0.000159	0.0281	CbGeAlD
Levonordefrin—ADRA2C—pituitary gland—obesity	0.000158	0.0279	CbGeAlD
Levonordefrin—ADRA2C—adipose tissue—obesity	0.000157	0.0277	CbGeAlD
Levonordefrin—ADRA1A—adrenal gland—obesity	0.000148	0.0261	CbGeAlD
Levonordefrin—ADRA2C—adrenal gland—obesity	0.000141	0.0249	CbGeAlD
Levonordefrin—SLC6A2—endocrine gland—obesity	0.000138	0.0244	CbGeAlD
Levonordefrin—ADRA1A—endocrine gland—obesity	0.000128	0.0227	CbGeAlD
Levonordefrin—Methyldopa—COMT—obesity	0.000128	0.0562	CrCbGaD
Levonordefrin—ADRA2A—pituitary gland—obesity	0.000126	0.0222	CbGeAlD
Levonordefrin—ADRA2A—adipose tissue—obesity	0.000125	0.0221	CbGeAlD
Levonordefrin—ADRA1A—liver—obesity	0.000115	0.0204	CbGeAlD
Levonordefrin—ADRA2A—adrenal gland—obesity	0.000112	0.0199	CbGeAlD
Levonordefrin—Droxidopa—ADRB3—obesity	0.000112	0.0494	CrCbGaD
Levonordefrin—Isoetarine—ADRB1—obesity	0.000111	0.0489	CrCbGaD
Levonordefrin—ADRA2C—liver—obesity	0.00011	0.0195	CbGeAlD
Levonordefrin—Isoprenaline—ADRB3—obesity	0.000102	0.0449	CrCbGaD
Levonordefrin—ADRA2A—endocrine gland—obesity	9.74e-05	0.0172	CbGeAlD
Levonordefrin—Norepinephrine—ADRB3—obesity	9.44e-05	0.0415	CrCbGaD
Levonordefrin—Isoetarine—ADRB2—obesity	9.33e-05	0.0411	CrCbGaD
Levonordefrin—Salbutamol—ADRB1—obesity	8.57e-05	0.0377	CrCbGaD
Levonordefrin—Epinephrine—ADRB3—obesity	8.56e-05	0.0377	CrCbGaD
Levonordefrin—Salbutamol—ADRB2—obesity	7.21e-05	0.0317	CrCbGaD
Levonordefrin—Dopamine—COMT—obesity	6.23e-05	0.0274	CrCbGaD
Levonordefrin—Phenylpropanolamine—DRD1—obesity	5.95e-05	0.0262	CrCbGaD
Levonordefrin—Norepinephrine—SLC22A1—obesity	5.62e-05	0.0248	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB1—obesity	5.52e-05	0.0243	CrCbGaD
Levonordefrin—L-DOPA—DRD4—obesity	5.43e-05	0.0239	CrCbGaD
Levonordefrin—Dopamine—SLC22A1—obesity	5.23e-05	0.023	CrCbGaD
Levonordefrin—Epinephrine—SLC22A1—obesity	5.1e-05	0.0225	CrCbGaD
Levonordefrin—Droxidopa—ADRB1—obesity	5.07e-05	0.0223	CrCbGaD
Levonordefrin—Dopamine—DRD4—obesity	5.05e-05	0.0222	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB2—obesity	4.64e-05	0.0204	CrCbGaD
Levonordefrin—Isoprenaline—ADRB1—obesity	4.61e-05	0.0203	CrCbGaD
Levonordefrin—L-DOPA—DRD1—obesity	4.6e-05	0.0202	CrCbGaD
Levonordefrin—Dopamine—DRD1—obesity	4.27e-05	0.0188	CrCbGaD
Levonordefrin—Norepinephrine—ADRB1—obesity	4.27e-05	0.0188	CrCbGaD
Levonordefrin—Droxidopa—ADRB2—obesity	4.26e-05	0.0188	CrCbGaD
Levonordefrin—Dopamine—ADRB1—obesity	3.97e-05	0.0175	CrCbGaD
Levonordefrin—Isoprenaline—ADRB2—obesity	3.87e-05	0.0171	CrCbGaD
Levonordefrin—Epinephrine—ADRB1—obesity	3.87e-05	0.017	CrCbGaD
Levonordefrin—Epinephrine—TNF—obesity	3.67e-05	0.0162	CrCbGaD
Levonordefrin—Norepinephrine—ADRB2—obesity	3.59e-05	0.0158	CrCbGaD
Levonordefrin—Epinephrine—ADRB2—obesity	3.26e-05	0.0143	CrCbGaD
Levonordefrin—Norepinephrine—DRD2—obesity	3.24e-05	0.0143	CrCbGaD
Levonordefrin—L-DOPA—DRD2—obesity	3.24e-05	0.0143	CrCbGaD
Levonordefrin—Dopamine—SLC6A4—obesity	3.03e-05	0.0133	CrCbGaD
Levonordefrin—Dopamine—DRD2—obesity	3.01e-05	0.0133	CrCbGaD
Levonordefrin—ADRA2C—Signaling Pathways—LPL—obesity	2.56e-06	6.31e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—obesity	2.55e-06	6.28e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CAV1—obesity	2.54e-06	6.27e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SOCS1—obesity	2.54e-06	6.26e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FOXO1—obesity	2.54e-06	6.26e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RPS6KB1—obesity	2.54e-06	6.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOA1—obesity	2.54e-06	6.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—POMC—obesity	2.53e-06	6.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRL—obesity	2.53e-06	6.23e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PRKCD—obesity	2.53e-06	6.22e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CD—obesity	2.52e-06	6.21e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CB—obesity	2.51e-06	6.19e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SOCS3—obesity	2.51e-06	6.19e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STK11—obesity	2.49e-06	6.14e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—LPL—obesity	2.49e-06	6.13e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL2—obesity	2.48e-06	6.11e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR2A—obesity	2.47e-06	6.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—C3—obesity	2.47e-06	6.08e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PLG—obesity	2.46e-06	6.07e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—RHOA—obesity	2.46e-06	6.06e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GNB3—obesity	2.46e-06	6.06e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT2—obesity	2.44e-06	6e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3R1—obesity	2.43e-06	6e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GPX1—obesity	2.43e-06	5.98e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—TYK2—obesity	2.42e-06	5.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	2.42e-06	5.96e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF2—obesity	2.41e-06	5.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FOXO3—obesity	2.4e-06	5.92e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—RHOA—obesity	2.4e-06	5.92e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB2—obesity	2.4e-06	5.91e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GNAS—obesity	2.39e-06	5.9e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3R1—obesity	2.38e-06	5.86e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CD36—obesity	2.36e-06	5.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SOCS1—obesity	2.36e-06	5.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PRKCD—obesity	2.36e-06	5.81e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS2—obesity	2.35e-06	5.78e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGT—obesity	2.34e-06	5.78e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOB—obesity	2.34e-06	5.78e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CD—obesity	2.34e-06	5.77e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—AKT1—obesity	2.33e-06	5.75e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SOCS3—obesity	2.33e-06	5.75e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CG—obesity	2.32e-06	5.71e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR2A—obesity	2.31e-06	5.69e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—C3—obesity	2.31e-06	5.68e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—obesity	2.3e-06	5.66e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—obesity	2.3e-06	5.66e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL5—obesity	2.29e-06	5.64e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GNB3—obesity	2.28e-06	5.63e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CAV1—obesity	2.28e-06	5.61e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOA1—obesity	2.27e-06	5.6e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—TYK2—obesity	2.25e-06	5.55e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	2.25e-06	5.54e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF2—obesity	2.24e-06	5.53e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—obesity	2.24e-06	5.52e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LPL—obesity	2.24e-06	5.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARG—obesity	2.24e-06	5.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—RHOA—obesity	2.23e-06	5.5e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GNAS—obesity	2.22e-06	5.48e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FOXO1—obesity	2.22e-06	5.47e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RPS6KB1—obesity	2.22e-06	5.46e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3R1—obesity	2.21e-06	5.45e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—POMC—obesity	2.2e-06	5.43e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARA—obesity	2.2e-06	5.41e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CB—obesity	2.2e-06	5.41e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ESR1—obesity	2.19e-06	5.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS2—obesity	2.19e-06	5.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—INS—obesity	2.19e-06	5.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGT—obesity	2.19e-06	5.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT1—obesity	2.18e-06	5.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOB—obesity	2.18e-06	5.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PIK3CA—obesity	2.17e-06	5.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—F2—obesity	2.17e-06	5.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PRKCB—obesity	2.17e-06	5.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—obesity	2.15e-06	5.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—obesity	2.15e-06	5.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BAD—obesity	2.14e-06	5.27e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AGT—obesity	2.13e-06	5.24e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL5—obesity	2.13e-06	5.24e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CAV1—obesity	2.13e-06	5.24e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOA1—obesity	2.12e-06	5.23e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—obesity	2.08e-06	5.14e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LPL—obesity	2.08e-06	5.12e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CG—obesity	2.07e-06	5.11e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CAV1—obesity	2.07e-06	5.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FOXO1—obesity	2.06e-06	5.09e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRKCD—obesity	2.06e-06	5.08e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RPS6KB1—obesity	2.06e-06	5.08e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOA1—obesity	2.06e-06	5.08e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IRS1—obesity	2.05e-06	5.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ESR1—obesity	2.05e-06	5.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CB—obesity	2.04e-06	5.03e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CD—obesity	2.04e-06	5.02e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—F2—obesity	2.02e-06	4.99e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PRKCB—obesity	2.02e-06	4.99e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR2A—obesity	2.02e-06	4.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—C3—obesity	2.02e-06	4.96e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALB—obesity	2.01e-06	4.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BAD—obesity	2e-06	4.93e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—POMC—obesity	1.97e-06	4.86e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INS—obesity	1.96e-06	4.84e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CG—obesity	1.94e-06	4.77e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL2—obesity	1.93e-06	4.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3R1—obesity	1.92e-06	4.74e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—obesity	1.92e-06	4.74e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS2—obesity	1.92e-06	4.72e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRKCD—obesity	1.92e-06	4.72e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGT—obesity	1.91e-06	4.72e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IRS1—obesity	1.91e-06	4.72e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—obesity	1.9e-06	4.68e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT2—obesity	1.9e-06	4.67e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CG—obesity	1.88e-06	4.64e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—obesity	1.88e-06	4.62e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—obesity	1.88e-06	4.62e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR2A—obesity	1.87e-06	4.62e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—C3—obesity	1.87e-06	4.61e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CAV1—obesity	1.86e-06	4.58e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOA1—obesity	1.85e-06	4.57e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—POMC—obesity	1.84e-06	4.54e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INS—obesity	1.83e-06	4.52e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CD—obesity	1.82e-06	4.49e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—obesity	1.82e-06	4.47e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	1.81e-06	4.45e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL2—obesity	1.8e-06	4.44e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SERPINE1—obesity	1.8e-06	4.44e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ESR1—obesity	1.79e-06	4.41e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—POMC—obesity	1.79e-06	4.41e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS2—obesity	1.78e-06	4.39e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—INS—obesity	1.78e-06	4.39e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGT—obesity	1.78e-06	4.38e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CB—obesity	1.77e-06	4.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—obesity	1.77e-06	4.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT2—obesity	1.77e-06	4.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT1—obesity	1.77e-06	4.36e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—F2—obesity	1.77e-06	4.36e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRKCB—obesity	1.77e-06	4.36e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—obesity	1.76e-06	4.33e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TYK2—obesity	1.75e-06	4.32e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BAD—obesity	1.75e-06	4.31e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—obesity	1.74e-06	4.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—obesity	1.74e-06	4.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RHOA—obesity	1.74e-06	4.28e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CAV1—obesity	1.73e-06	4.26e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOA1—obesity	1.72e-06	4.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3R1—obesity	1.72e-06	4.24e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—obesity	1.72e-06	4.24e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CD—obesity	1.7e-06	4.19e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.69e-06	4.17e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	1.69e-06	4.16e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SERPINE1—obesity	1.68e-06	4.15e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IRS1—obesity	1.67e-06	4.12e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ESR1—obesity	1.66e-06	4.1e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CD—obesity	1.65e-06	4.07e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—F2—obesity	1.64e-06	4.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRKCB—obesity	1.64e-06	4.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.64e-06	4.04e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TYK2—obesity	1.64e-06	4.04e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALB—obesity	1.63e-06	4.02e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RHOA—obesity	1.62e-06	4e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BAD—obesity	1.62e-06	4e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—POMC—obesity	1.61e-06	3.97e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3R1—obesity	1.61e-06	3.96e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—obesity	1.61e-06	3.96e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INS—obesity	1.6e-06	3.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.59e-06	3.91e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MTOR—obesity	1.59e-06	3.91e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL2—obesity	1.58e-06	3.89e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.57e-06	3.88e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—obesity	1.56e-06	3.85e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3R1—obesity	1.56e-06	3.85e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IRS1—obesity	1.55e-06	3.83e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—obesity	1.55e-06	3.82e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT2—obesity	1.55e-06	3.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CA—obesity	1.53e-06	3.77e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—POMC—obesity	1.5e-06	3.69e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INS—obesity	1.49e-06	3.67e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.49e-06	3.67e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CB—obesity	1.48e-06	3.66e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MTOR—obesity	1.48e-06	3.66e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.47e-06	3.63e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.47e-06	3.63e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.47e-06	3.63e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL2—obesity	1.47e-06	3.61e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—obesity	1.45e-06	3.58e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CB—obesity	1.44e-06	3.55e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—obesity	1.44e-06	3.55e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT2—obesity	1.44e-06	3.55e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TYK2—obesity	1.43e-06	3.53e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—obesity	1.43e-06	3.52e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RHOA—obesity	1.42e-06	3.5e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.41e-06	3.46e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—obesity	1.41e-06	3.46e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.38e-06	3.41e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—obesity	1.38e-06	3.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT1—obesity	1.38e-06	3.39e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.37e-06	3.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.37e-06	3.37e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—obesity	1.36e-06	3.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK8—obesity	1.34e-06	3.31e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT1—obesity	1.34e-06	3.3e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.34e-06	3.3e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TYK2—obesity	1.33e-06	3.28e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RHOA—obesity	1.32e-06	3.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—obesity	1.31e-06	3.22e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.31e-06	3.22e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MTOR—obesity	1.3e-06	3.2e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CB—obesity	1.3e-06	3.2e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—obesity	1.29e-06	3.18e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK8—obesity	1.25e-06	3.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT1—obesity	1.25e-06	3.08e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.24e-06	3.06e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STAT3—obesity	1.23e-06	3.03e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MTOR—obesity	1.21e-06	2.97e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.21e-06	2.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT1—obesity	1.2e-06	2.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—obesity	1.19e-06	2.92e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STAT3—obesity	1.15e-06	2.83e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—obesity	1.14e-06	2.81e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—obesity	1.14e-06	2.8e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—obesity	1.13e-06	2.78e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.12e-06	2.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—obesity	1.1e-06	2.71e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK8—obesity	1.1e-06	2.7e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT1—obesity	1.09e-06	2.69e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CA—obesity	1.08e-06	2.67e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—obesity	1.07e-06	2.63e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—obesity	1.06e-06	2.62e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—obesity	1.05e-06	2.58e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK8—obesity	1.02e-06	2.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT1—obesity	1.02e-06	2.5e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STAT3—obesity	1e-06	2.47e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CA—obesity	9.68e-07	2.39e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—obesity	9.32e-07	2.3e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STAT3—obesity	9.32e-07	2.3e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—obesity	9.29e-07	2.29e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CA—obesity	9.05e-07	2.23e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKT1—obesity	8.84e-07	2.18e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CA—obesity	8.79e-07	2.17e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—obesity	8.66e-07	2.13e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—obesity	8.64e-07	2.13e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—obesity	8.58e-07	2.11e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—obesity	8.01e-07	1.97e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT1—obesity	7.91e-07	1.95e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CA—obesity	7.91e-07	1.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT1—obesity	7.39e-07	1.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CA—obesity	7.35e-07	1.81e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKT1—obesity	7.18e-07	1.77e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—obesity	7e-07	1.73e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—obesity	6.51e-07	1.6e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT1—obesity	6.46e-07	1.59e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT1—obesity	6e-07	1.48e-05	CbGpPWpGaD
